Khan Najat
Reporting owner on Forms 3, 4 and 5, CIK 2020969.
Khan Najat reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, INC.CIK 1601830 | director, officer (CEO and President) | 1 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, …Class A Common Stock | 2026-11-16 | F withheld for tax | -85,815 | $3.185 | 1,987,075 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001601830-26-000155 | RECURSION PHARMACEUTICALS, INC. | 2026-11-18 |